132 related articles for article (PubMed ID: 30241142)
21. Editorial: Recent Advances in Molecular Detection of Human Papillomavirus and Cervical Cancer Screening.
Poljak M; Ginocchio CC
J Clin Virol; 2016 Mar; 76 Suppl 1():S1-S2. PubMed ID: 26597652
[No Abstract] [Full Text] [Related]
22. Re: Alternative cervical cancer prevention in low-resource settings: experiences of visual inspection by acetic acid with single-visit approach in the first five provinces of Thailand.
Gaikwad NL; Mahajan NN; Mahajan KN
Aust N Z J Obstet Gynaecol; 2007 Jun; 47(3):258-9; author reply 259. PubMed ID: 17550500
[No Abstract] [Full Text] [Related]
23. Detection of human papillomavirus DNA in routine cervical scraping samples: use for a national cervical cancer screening program in a developing nation.
Othman N; Othman NH
Asian Pac J Cancer Prev; 2014; 15(5):2245-9. PubMed ID: 24716964
[TBL] [Abstract][Full Text] [Related]
24. [Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China].
Li LY; Qiao ZQ; Zhang MF; Yang JP; Bao YP; An YT; Lei J; Xiong NH; Yu XH; Zhang X; Pan QJ; Qiao YL
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):964-7. PubMed ID: 18399140
[TBL] [Abstract][Full Text] [Related]
25. Early detection of cervical cancer through acetic acid application--an aided visual inspection.
Singh V; Sehgal A; Parashari A; Sodhani P; Satyanarayana L
Singapore Med J; 2001 Aug; 42(8):351-4. PubMed ID: 11764051
[TBL] [Abstract][Full Text] [Related]
26. Calls for cervical screening should treat women like adults.
McCartney M
BMJ; 2023 Nov; 383():2772. PubMed ID: 38000792
[No Abstract] [Full Text] [Related]
27. Cervical cancer screening in low- and middle-income countries.
Ditzian LR; David-West G; Maza M; Hartmann B; Shirazian T; Cremer M
Mt Sinai J Med; 2011; 78(3):319-26. PubMed ID: 21598259
[TBL] [Abstract][Full Text] [Related]
28. Performance of visual inspection with acetic acid for cervical cancer screening: a qualitative summary of evidence to date.
Gaffikin L; Lauterbach M; Blumenthal PD
Obstet Gynecol Surv; 2003 Aug; 58(8):543-50. PubMed ID: 12886165
[TBL] [Abstract][Full Text] [Related]
29. Use of visual inspection with acetic acid, Pap smear, or high-risk human papillomavirus testing in women living with HIV/AIDS for posttreatment cervical cancer screening: same tests, different priorities.
Omenge Orang'o E; Liu T; Christoffersen-Deb A; Itsura P; Oguda J; Washington S; Chumba D; Pisharodi L; Cu-Uvin S; Rositch AF
AIDS; 2017 Jan; 31(2):233-240. PubMed ID: 28002084
[TBL] [Abstract][Full Text] [Related]
30. Screening for Cervical Cancer: New Tools and New Opportunities.
Learman LA; Garcia FAR
JAMA; 2018 Aug; 320(7):647-649. PubMed ID: 30140859
[No Abstract] [Full Text] [Related]
31. Reasons for variation in sensitivity and specificity of visual inspection with acetic acid (VIA) for the detection of pre- cancer and cancer lesions of uterine cervix.
Parashari A; Singh V
Asian Pac J Cancer Prev; 2013; 14(12):7761-2. PubMed ID: 24460365
[TBL] [Abstract][Full Text] [Related]
32. Self-sampling for high-risk human papillomavirus detection: future cervical cancer screening?
Daponte A; Pournaras S; Tsakris A
Womens Health (Lond); 2014 Mar; 10(2):115-8. PubMed ID: 24601801
[No Abstract] [Full Text] [Related]
33. Prior cervical cytology and high-risk HPV testing results for 311 patients with invasive cervical adenocarcinoma: a multicenter retrospective study from China's largest independent operator of pathology laboratories.
Xie F; Zhang L; Zhao D; Wu X; Wei M; Zhang X; Wu X; Fang H; Xu X; Yang M; Qi D
BMC Infect Dis; 2019 Nov; 19(1):962. PubMed ID: 31711435
[TBL] [Abstract][Full Text] [Related]
34. Multiplex polymerase chain reaction for the detection of high-risk-human papillomavirus types in formalin-fixed paraffin-embedded cervical tissues.
Singh MP; Gupta N; Deepak T; Kumar A; Ratho RK
Indian J Med Microbiol; 2017; 35(1):113-115. PubMed ID: 28303830
[TBL] [Abstract][Full Text] [Related]
35. Health impact of delayed implementation of cervical cancer screening programs in India: A modeling analysis.
Campos NG; Tsu V; Jeronimo J; Regan C; Resch S; Clark A; Sy S; Kim JJ
Int J Cancer; 2019 Feb; 144(4):687-696. PubMed ID: 30132850
[TBL] [Abstract][Full Text] [Related]
36. Cervical cancer screening in low-resource settings: A cost-effectiveness framework for valuing tradeoffs between test performance and program coverage.
Campos NG; Castle PE; Wright TC; Kim JJ
Int J Cancer; 2015 Nov; 137(9):2208-19. PubMed ID: 25943074
[TBL] [Abstract][Full Text] [Related]
37. Implementing community-based cervical cancer screening programs using visual inspection with acetic acid in India: A systematic review.
Adsul P; Manjunath N; Srinivas V; Arun A; Madhivanan P
Cancer Epidemiol; 2017 Aug; 49():161-174. PubMed ID: 28704717
[TBL] [Abstract][Full Text] [Related]
38. HPV self-testing for primary cervical cancer screening in Madagascar: VIA/VILI triage compliance in HPV-positive women.
Benski AC; Viviano M; Jinoro J; Alec M; Catarino R; Herniainasolo J; Vassilakos P; Petignat P
PLoS One; 2019; 14(8):e0220632. PubMed ID: 31408474
[TBL] [Abstract][Full Text] [Related]
39. Testing for human papillomavirus in cervical cancer screening: a review of indications and methodology.
Nishino HT; Tambouret RH; Wilbur DC
Cancer Cytopathol; 2011 Aug; 119(4):219-27. PubMed ID: 21717588
[TBL] [Abstract][Full Text] [Related]
40. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
